[Clinical aspects of the polymorphism of oxidation phenotype]
- PMID: 1488339
[Clinical aspects of the polymorphism of oxidation phenotype]
Similar articles
-
[The genetically determined polymorphism of metabolic oxidation of the sparteine-debrisoquin type].Farmakol Toksikol. 1991 Nov-Dec;54(6):60-6. Farmakol Toksikol. 1991. PMID: 1804700 Review. Russian. No abstract available.
-
The relationship between imipramine metabolism and the sparteine oxidation polymorphism.Dan Med Bull. 1988 Oct;35(5):460-8. Dan Med Bull. 1988. PMID: 3066590 Review. No abstract available.
-
Polymorphic oxidation of debrisoquine and sparteine.Prog Clin Biol Res. 1986;214:157-67. Prog Clin Biol Res. 1986. PMID: 3523506 Review. No abstract available.
-
[Genetic polymorphism of the hepatic metabolism of drugs].Gastroenterol Clin Biol. 1985 Jun-Jul;9(6-7):522-31. Gastroenterol Clin Biol. 1985. PMID: 3926587 Review. French. No abstract available.
-
[The significance of cytochrome P450 gene superfamily for the clinical pharmacokinetics of drugs].Ugeskr Laeger. 1991 Feb 4;153(6):417-22. Ugeskr Laeger. 1991. PMID: 2000644 Review. Danish.